NEW YORK–(BUSINESS WIRE)–Jan. 3, 2019– IVERIC bio Corporation (NASDAQ: ISEE) announced today that Glenn P. Sblendorio, Chief Executive Officer and President, will present an overview of the Company at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Thursday, January 10, 2019 at 10:00 a.m. Pacific Time (1:00 p.m. Eastern Time).
Investors and the general public are invited to listen to a live webcast of the presentation at www.ivericbio.com. Please connect to IVERIC bio’s website several minutes prior to the start of the presentation to ensure adequate time for any software download that may be necessary. A replay will be available for 14 days following the presentation.
About IVERIC bio Corporation
IVERIC bio is a biopharmaceutical company specializing in the development of novel therapies to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. For more information, please visit www.ivericbio.com.
Any statements in this press release about IVERIC bio’s future expectations, plans and prospects constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors. Any forward-looking statements represent IVERIC bio’s views only as of the date of this press release. IVERIC bio anticipates that subsequent events and developments will cause its views to change. While IVERIC bio may elect to update these forward-looking statements at some point in the future, IVERIC bio specifically disclaims any obligation to do so.
Source: IVERIC bio Corporation
IVERIC bio Corporation
Vice President, Investor Relations and Corporate Communications
Alex Van Rees
SmithSolve LLC on behalf of IVERIC bio Corporation
973-442-1555 ext. 111